Inducible epithelial resistance protects mice against leukemia-associated pneumonia
Open Access
- 18 August 2016
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 128 (7) , 982-992
Abstract
Key Points: Survival of acute myelogenous leukemia is frequently limited by pneumonia, due to disease- and therapy-associated immune defects. Inducible epithelial resistance protects neutropenic, leukemic mice against lethal pneumonia without impacting AML cell proliferation.Keywords
This publication has 44 references indexed in Scilit:
- Synergistic TLR2/6 and TLR9 Activation Protects Mice against Lethal Influenza PneumoniaPLOS ONE, 2012
- Synergistic Interactions of TLR2/6 and TLR9 Induce a High Level of Resistance to Lung Infection in MiceThe Journal of Immunology, 2011
- Inhaled innate immune ligands to prevent pneumoniaBritish Journal of Pharmacology, 2011
- Stimulated Innate Resistance of Lung Epithelium Protects Mice Broadly against Bacteria and FungiAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Basal cells as stem cells of the mouse trachea and human airway epitheliumProceedings of the National Academy of Sciences, 2009
- Infections and association with different intensity of chemotherapy in children with acute myeloid leukemiaCancer, 2009
- Toll-like Receptors Activate Innate and Adaptive Immunity by using Dendritic Cell-Intrinsic and -Extrinsic MechanismsImmunity, 2008
- Stimulation of Lung Innate Immunity Protects against Lethal Pneumococcal Pneumonia in MiceAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Lung development and repair: Contribution of the ciliated lineageProceedings of the National Academy of Sciences, 2007
- Lung Infection—A Public Health PriorityPLOS Medicine, 2006